Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
11 2019
Historique:
received: 18 02 2019
accepted: 15 10 2019
pubmed: 22 11 2019
medline: 14 4 2020
entrez: 22 11 2019
Statut: ppublish

Résumé

Caspase-8 is the initiator caspase of extrinsic apoptosis

Identifiants

pubmed: 31748744
doi: 10.1038/s41586-019-1770-6
pii: 10.1038/s41586-019-1770-6
doi:

Substances chimiques

Inflammasomes 0
Receptor, TIE-2 EC 2.7.10.1
Tek protein, mouse EC 2.7.10.1
Caspase 8 EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

683-687

Références

Muzio, M. et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817–827 (1996).
doi: 10.1016/S0092-8674(00)81266-0
Boldin, M. P., Goncharov, T. M., Goltsev, Y. V. & Wallach, D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85, 803–815 (1996).
doi: 10.1016/S0092-8674(00)81265-9
Varfolomeev, E. E. et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267–276 (1998).
doi: 10.1016/S1074-7613(00)80609-3
Kaiser, W. J. et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368–372 (2011).
doi: 10.1038/nature09857
Oberst, A. et al. Catalytic activity of the caspase-8-FLIP
doi: 10.1038/nature09852
Alvarez-Diaz, S. et al. The pseudokinase MLKL and the kinase RIPK3 have distinct roles in autoimmune disease caused by loss of death-receptor-induced apoptosis. Immunity 45, 513–526 (2016).
doi: 10.1016/j.immuni.2016.07.016
Kang, T. B. et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J. Immunol. 173, 2976–2984 (2004).
doi: 10.4049/jimmunol.173.5.2976
Günther, C. et al. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature 477, 335–339 (2011).
doi: 10.1038/nature10400
Hartwig, T. et al. The TRAIL-induced cancer secretome promotes a tumor-supportive immune microenvironment via CCR2. Mol. Cell 65, 730–742 (2017).
doi: 10.1016/j.molcel.2017.01.021
Henry, C. M. & Martin, S. J. Caspase-8 acts in a non-enzymatic role as a scaffold for assembly of a pro-inflammatory “FADDosome” complex upon TRAIL stimulation. Mol. Cell 65, 715–729 (2017).
doi: 10.1016/j.molcel.2017.01.022
Kang, S. et al. Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat. Commun. 6, 7515 (2015).
doi: 10.1038/ncomms8515
Philip, N. H. et al. Activity of uncleaved Caspase-8 controls anti-bacterial immune defense and TLR-induced cytokine production independent of cell death. PLoS Pathog. 12, e1005910 (2016).
doi: 10.1371/journal.ppat.1005910
Su, H. et al. Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 307, 1465–1468 (2005).
doi: 10.1126/science.1104765
Constien, R. et al. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 30, 36–44 (2001).
doi: 10.1002/gene.1030
Hafner, M. et al. Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte-expressed protein. Genesis 38, 176–181 (2004).
doi: 10.1002/gene.20016
Madison, B. B. et al. cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J. Biol. Chem. 277, 33275–33283 (2002).
doi: 10.1074/jbc.M204935200
Kovalenko, A. et al. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J. Exp. Med. 206, 2161–2177 (2009).
doi: 10.1084/jem.20090616
Peitz, M., Pfannkuche, K., Rajewsky, K. & Edenhofer, F. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc. Natl Acad. Sci. USA 99, 4489–4494 (2002).
doi: 10.1073/pnas.032068699
Dannappel, M. et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513, 90–94 (2014).
doi: 10.1038/nature13608
Broz, P. & Dixit, V. M. Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16, 407–420 (2016).
doi: 10.1038/nri.2016.58
Van Gorp, H. et al. Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation. Proc. Natl Acad. Sci. USA 113, 14384–14389 (2016).
doi: 10.1073/pnas.1613156113
Drexler, S. K. et al. Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proc. Natl Acad. Sci. USA 109, 18384–18389 (2012).
doi: 10.1073/pnas.1209171109
Chen, M. et al. Internalized Cryptococcus neoformans activates the canonical caspase-1 and the noncanonical caspase-8 inflammasomes. J. Immunol. 195, 4962–4972 (2015).
doi: 10.4049/jimmunol.1500865
Man, S. M. et al. Salmonella infection induces recruitment of caspase-8 to the inflammasome to modulate IL-1β production. J. Immunol. 191, 5239–5246 (2013).
doi: 10.4049/jimmunol.1301581
Pierini, R. et al. AIM2/ASC triggers caspase-8-dependent apoptosis in Francisella-infected caspase-1-deficient macrophages. Cell Death Differ. 19, 1709–1721 (2012).
doi: 10.1038/cdd.2012.51
Van Opdenbosch, N. et al. Caspase-1 engagement and TLR-induced c-FLIP expression suppress ASC/Caspase-8-dependent apoptosis by inflammasome sensors NLRP1b and NLRC4. Cell Rep. 21, 3427–3444 (2017).
doi: 10.1016/j.celrep.2017.11.088
Gurung, P. et al. FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. J. Immunol. 192, 1835–1846 (2014).
doi: 10.4049/jimmunol.1302839
Mocarski, E. S., Upton, J. W. & Kaiser, W. J. Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat. Rev. Immunol. 12, 79–88 (2013).
doi: 10.1038/nri3131
Witt, A. et al. IAP antagonization promotes inflammatory destruction of vascular endothelium. EMBO Rep. 16, 719–727 (2015).
doi: 10.15252/embr.201439616
Andree, M. et al. BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella. EMBO J. 33, 2171–2187 (2014).
doi: 10.15252/embj.201387244
Kashkar, H. et al. XIAP-mediated caspase inhibition in Hodgkin’s lymphoma-derived B cells. J. Exp. Med. 198, 341–347 (2003).
doi: 10.1084/jem.20021279

Auteurs

Melanie Fritsch (M)

Institute for Medical Microbiology, Immunology and Hygiene (IMMIH), CECAD Research Center, University of Cologne, Cologne, Germany.

Saskia D Günther (SD)

Institute for Medical Microbiology, Immunology and Hygiene (IMMIH), CECAD Research Center, University of Cologne, Cologne, Germany.

Robin Schwarzer (R)

Institute for Genetics, CECAD Research Center, University of Cologne, Cologne, Germany.

Marie-Christine Albert (MC)

Institute for Medical Microbiology, Immunology and Hygiene (IMMIH), CECAD Research Center, University of Cologne, Cologne, Germany.

Fabian Schorn (F)

Institute for Medical Microbiology, Immunology and Hygiene (IMMIH), CECAD Research Center, University of Cologne, Cologne, Germany.

J Paul Werthenbach (JP)

Institute for Medical Microbiology, Immunology and Hygiene (IMMIH), CECAD Research Center, University of Cologne, Cologne, Germany.

Lars M Schiffmann (LM)

Institute for Medical Microbiology, Immunology and Hygiene (IMMIH), CECAD Research Center, University of Cologne, Cologne, Germany.
Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany.

Neil Stair (N)

Institute for Medical Microbiology, Immunology and Hygiene (IMMIH), CECAD Research Center, University of Cologne, Cologne, Germany.
Institute for Genetics, CECAD Research Center, University of Cologne, Cologne, Germany.

Hannah Stocks (H)

Institute for Medical Microbiology, Immunology and Hygiene (IMMIH), CECAD Research Center, University of Cologne, Cologne, Germany.

Jens M Seeger (JM)

Institute for Medical Microbiology, Immunology and Hygiene (IMMIH), CECAD Research Center, University of Cologne, Cologne, Germany.

Mohamed Lamkanfi (M)

Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
VIB Center for Inflammation Research, Ghent, Belgium.

Martin Krönke (M)

Institute for Medical Microbiology, Immunology and Hygiene (IMMIH), CECAD Research Center, University of Cologne, Cologne, Germany.

Manolis Pasparakis (M)

Institute for Genetics, CECAD Research Center, University of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.

Hamid Kashkar (H)

Institute for Medical Microbiology, Immunology and Hygiene (IMMIH), CECAD Research Center, University of Cologne, Cologne, Germany. h.kashkar@uni-koeln.de.
Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. h.kashkar@uni-koeln.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH